Pilot test targeting HIV prevention for people who inject drugs
Part of Infections, Lungs & breathing clinical trials.
This pilot program studies where HIV risk is highest and uses that information to decide how prevention efforts should be delivered. If you’ve used opioids recently and you inject drugs, you may be invited to participate to help reduce HIV risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Used opioids within the last 2 weeks
- You are part of the group who injects drugs
- You’re willing to take part in a pilot (small) study
- There are no specific listed health exclusions for this trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
This study tests how well a program combining telemedicine (virtual doctor visits) and peer support can help prevent HIV among people who inject drugs. You'd get trained, attend weekly group sessions, and invite a friend or partner to also take part.
This study tests if a program that encourages positive activities (behavioral activation) can help people with HIV or on PrEP who also use substances improve their health. It focuses on those receiving long-acting injectable medications for HIV prevention or treatment.
This study tests whether an internet-based HIV prevention program works for people who use injection drugs. Researchers want to see if online tools can help reduce HIV risk and improve health outcomes.
This project studies how to improve offering and completing HIV (and hepatitis C) tests in opioid treatment programs. It may help increase timely follow-up and linkage to care when results are positive.
This study tests a telehealth program that provides support for people who inject drugs, focusing on preventing HIV and improving care for hepatitis C. It is designed specifically for people living in rural areas of the Deep South and offers a phone or video-based program that is trauma-informed and builds resilience.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.